Clindamycin added to treat certain skin infections
Treatments studied
Part of Infections, Skin clinical trials.
This trial tests whether adding clindamycin helps treat skin and soft-tissue infections caused by Staphylococcus aureus. You may be eligible if your infection was diagnosed recently and a sample was collected soon after hospital admission.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a skin infection needing drainage (cut/open or drain) and possibly antibiotics
- A lab test from your infection sample shows Staphylococcus aureus (S. aureus)
- Your symptoms started within the last 4 weeks, and the sample was taken within 48 hours of hospital admission
- You can start study randomization within 72 hours after the first culture is collected and attend follow-up visits
- You have not had a previous allergic reaction to clindamycin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether the antibiotic clindamycin works well for treating joint replacement infections caused by strep bacteria. It may help people who had surgery for an infected artificial joint between 2013 and 2024.
This study tests if clindamycin, a common antibiotic, works as well as vancomycin to prevent infections during heart surgery on the aorta (the main artery from the heart). Patients must be having planned morning surgery with the heart-lung machine and understand French.
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
This trial tests whether adding linezolid, an antibiotic that stops bacteria from making proteins, to usual care works better for treating Staphylococcus aureus bloodstream infections. You may be eligible if you have this infection and are hospitalized.
This trial tests whether switching from IV antibiotics to oral antibiotics after 3–7 days is safe and effective for people with uncomplicated Staphylococcus aureus bloodstream infections. It may help you avoid a longer hospital stay and reduce IV-related complications.
This trial tests three different gel treatments for mild to moderate acne on the face. One gel contains clindamycin and retinoid, another adds dexamethasone, and the third uses a special stem-cell secretion. All are applied to the face for 8 weeks.
Hear when a new Skin Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.